Cancéropôle Est

Name

Cancéropôle Est

Legal name

Cancéropôle Est

Website

https://canceropole-est.org

Company type

Private

Founded year

2003

Operating status

Operating

Ownership category

akta.pro rank

Product category

Cancer Research Coordination Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Health Research Funding Agencies (Public/Quasi-Public) (HLAJALAB)

akta.pro secondary industry

Medical Oncology (HLAKAFAB)

Keywords

• Cancer research coordination
• Translational research networks
• Oncology funding programs
• Research platform services
• Scientific event organization

Headquarters

HQ city

Strasbourg

HQ country

France

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Public funding and institutional support: As an association under local law (loi 1908) presided by regional presidents, Cancéropôle Est receives funding from public sources including INCa (Institut National du Cancer) through contractual objectives and performance agreements (Contrat d'Objectifs et de Performance 2023-2027), regional governments, and potentially foundation support from Ligue contre le Cancer and Fondation ARC

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Cancéropôle Est is a non-profit cancer research coordination association that structures, animates, and funds collaborative cancer research across the Grand Est and Bourgogne-Franche-Comté regions. It operates five thematic research networks (Parcours de santé, Lésions prénéoplasiques, RIBIOTHIM-Onco, Biopsies liquides, Pancréas-CGE), runs an Emergence funding program, maintains the eSCAPE researcher platform, and organizes scientific forums, training, and cross-border collaborations with neighboring European countries.

Product overview

Cancéropôle Est is a cancer research coordination organization (association loi 1908) supporting innovative research across the Grand Est and Bourgogne-Franche-Comté regions of France. Rather than a commercial product company, it provides a portfolio of research networks, funding programs, training resources, and scientific events. Its core offerings include five thematic research networks (Parcours de santé, Lésions prénéoplasiques, RIBIOTHIM-Onco, Biopsies liquides, and Pancréas-CGE project), the eSCAPE platform for researchers, the Emergence funding programs for innovative projects, scientific training including the MOOC NGS & CANCER, and annual forums/conferences such as the Forum du Cancéropôle Est and international conferences on nanomedicine and innovative therapies.

Differentiator

Problem solved

Functional benefit

Products and services

• Réseau Parcours de santé Thematic research network on healthcare pathways, Human and Social Sciences, Epidemiology and Public Health in oncology, covering prevention, screening, patient support during care, and quality of life; aimed at researchers and clinicians in the interregion.
• Réseau Lésions prénéoplasiques Research network studying the mechanisms of pre-neoplastic lesion progression and regression, with the goal of identifying biomarkers and risk factors for early detection and interception before lesions progress to cancer; aimed at researchers and clinicians in the interregion.
• Réseau RIBIOTHIM-Onco Research network on ionizing radiations in biology, combined therapies and molecular imaging, covering external radiotherapy, vectorized internal radiotherapy, radio-sensitizing nanoparticles, and combinations with immunotherapy; aimed at researchers and clinicians in the interregion.
• Réseau Biopsies liquides Research network dedicated to liquid biopsy research for cancer diagnosis and monitoring through analysis of biological fluids; aimed at researchers and clinicians in the interregion.
• Projet Pancréas-CGE

Named customers15 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

22 partnerships are on record, tiered core and minor.

• INCa (Institut National du Cancer)coreStrategic or Co-development Partner · 1 January 2023French National Cancer Institute - national coordination body with which Cancéropôle Est has a Contrat d'Objectifs et de Performance (2023-2027) defining missions and objectives
• CHU NancycoreStrategic or Co-development Partner · 1 January 2003Regional university hospital center partner providing clinical research capacity
• CHR Metz-ThionvillecoreStrategic or Co-development Partner · 1 January 2003Regional hospital center partner providing clinical research capacity
• Institut Strauss (Strasbourg)coreStrategic or Co-development Partner · 1 January 2003One of 4 cancer centers in the network, providing specialized oncology research and care
• Université de StrasbourgcoreStrategic or Co-development Partner · 1 January 2003One of the 5 partner universities in the Cancéropôle Est network, contributing researchers and academic resources to coordinated cancer research efforts across the interregion
• Université de BourgognecoreStrategic or Co-development Partner · 1 January 2003One of the 5 partner universities in the Cancéropôle Est network
• Université de Reims Champagne-ArdennecoreStrategic or Co-development Partner · 1 January 2003One of the 5 partner universities in the Cancéropôle Est network
• Université de Franche-ComtécoreStrategic or Co-development Partner · 1 January 2003One of the 5 partner universities in the Cancéropôle Est network
• Université de LorrainecoreStrategic or Co-development Partner · 1 January 2003One of the 5 partner universities in the Cancéropôle Est network
• CHU StrasbourgcoreStrategic or Co-development Partner · 1 January 2003Regional university hospital center partner providing clinical research capacity
• CHU DijoncoreStrategic or Co-development Partner · 1 January 2003Regional university hospital center partner providing clinical research capacity
• CHU ReimscoreStrategic or Co-development Partner · 1 January 2003Regional university hospital center partner providing clinical research capacity
• CHU BesançoncoreStrategic or Co-development Partner · 1 January 2003Regional university hospital center partner providing clinical research capacity
• Centre Georges-François Leclerc (Dijon)coreStrategic or Co-development Partner · 1 January 2003One of 4 cancer centers in the network, providing specialized oncology research and care
• Institut Jean Godinot (Reims)coreStrategic or Co-development Partner · 1 January 2003One of 4 cancer centers in the network, providing specialized oncology research and care
• Institut de Cancérologie de Lorraine (Nancy)coreStrategic or Co-development Partner · 1 January 2003One of 4 cancer centers in the network, providing specialized oncology research and care
• INSERMcoreStrategic or Co-development Partner · 1 January 2003French National Institute of Health and Medical Research - major national research organization partner providing scientific expertise and research capacity
• CNRScoreStrategic or Co-development Partner · 1 January 2003French National Centre for Scientific Research - major national research organization partner providing scientific expertise and research capacity
• INRIAcoreStrategic or Co-development Partner · 1 January 2003French National Institute for Research in Computer Science and Automation - national research organization partner contributing computational and digital research expertise
• Ligue nationale contre le CancerminorStrategic or Co-development Partner · 1 January 2003National cancer league represented in the Board of Directors, providing funding support through grants and scholarships
• Fondation ARCminorStrategic or Co-development Partner · 1 January 2003Cancer research foundation represented in the Board of Directors, providing funding support for research projects
• Cross-border partners (Germany, Belgium, Luxembourg, Switzerland)minorStrategic or Co-development PartnerProximity with European neighbors encourages cross-border dynamics on specific projects, including organization of symposiums, workshops, cross-border project calls (Emergence Transfrontalier), and mobility grants for young researchers

Scale indicators6 records

Direct peers

• Cancéropôle CLARA: Canceropôle Lyon Auvergne-Rhône-Alpes — sister Cancéropôle under the same French Cancer Plan 2003 architecture, performing the same cancer research coordination role across a different French interregion. Most structurally comparable peer.
• Cancéropôle Île-de-France: Paris-region Cancéropôle coordinating oncology research across Île-de-France's universities, AP-HP hospitals, and cancer centers under the same national framework as Cancéropôle Est.
• Cancéropôle Grand Ouest: Western France Cancéropôle (Brittany, Pays de la Loire, Normandy) coordinating oncology research networks, calls for projects, and clinical translation — direct institutional peer with identical mission.
• Cancéropôle Nord-Ouest: Northern France Cancéropôle coordinating cancer research across Hauts-de-France and other northern territories; same governance model under INCa performance contracts.
• Cancéropôle Sud-Méditerranée (PACA): Provence-Alpes-Côte d'Azur Cancéropôle coordinating oncology research in southern France; identical cancer-research coordination mandate and INCa contractual framework.
• Cancéropôle Grand Sud-Ouest (Occitanie): Southwestern France Cancéropôle (Toulouse, Occitanie) coordinating cancer research with the same national Cancer Plan governance as Cancéropôle Est.

Broad incumbents

• INCa (Institut National du Cancer): French national cancer agency that funds and contracts with all seven Cancéropôles. Operates at the national level as the umbrella counterpart and primary funder of Cancéropôle Est.
• EORTC (European Organisation for Research and Treatment of Cancer): European-level oncology research coordination organization running multi-country clinical trials and translational research programs; broader international equivalent of the Cancéropôle model.
• Cancer Research UK: Largest cancer research charity coordinating and funding UK oncology research across universities and hospitals; comparable as a multi-institutional research-funding and coordination body, though operating at much larger scale.

Others

• DGOS (Direction Générale de l'Offre de Soins): French directorate within the Ministry of Health that funds hospital-based research (PHRC, PHRIP) and overlaps with Cancéropôle Est's clinical research coordination role in public-sector oncology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/canceropole_est
• YouTubeyoutube.com/@canceropoleest/videos
• LinkedInlinkedin.com/company/canceropole-est

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cancéropôle Est